Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2008 2
2011 3
2015 1
2016 4
2019 4
2020 5
2021 6
2022 8
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Performance of plasma Aβ42/40, measured using a fully automated immunoassay, across a broad patient population in identifying amyloid status.
Bun S, Ito D, Tezuka T, Kubota M, Ueda R, Takahata K, Moriguchi S, Kurose S, Momota Y, Suzuki N, Morimoto A, Hoshino Y, Seki M, Mimura Y, Shikimoto R, Yamamoto Y, Hoshino T, Sato Y, Tabuchi H, Mimura M. Bun S, et al. Among authors: mimura y. Alzheimers Res Ther. 2023 Sep 4;15(1):149. doi: 10.1186/s13195-023-01296-5. Alzheimers Res Ther. 2023. PMID: 37667408 Free PMC article.
Neurophysiological biomarkers using transcranial magnetic stimulation in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis.
Mimura Y, Nishida H, Nakajima S, Tsugawa S, Morita S, Yoshida K, Tarumi R, Ogyu K, Wada M, Kurose S, Miyazaki T, Blumberger DM, Daskalakis ZJ, Chen R, Mimura M, Noda Y. Mimura Y, et al. Neurosci Biobehav Rev. 2021 Feb;121:47-59. doi: 10.1016/j.neubiorev.2020.12.003. Epub 2020 Dec 8. Neurosci Biobehav Rev. 2021. PMID: 33307047 Review.
Differentiating autoimmune encephalitis from schizophrenia spectrum disorders among patients with first-episode psychosis.
Funayama M, Koreki A, Takata T, Kurose S, Hisamatsu T, Ono A, Yagihashi T, Mizushima J, Yagi Y, Ogino S, Oi H, Mimura Y, Shimizu Y, Kudo S, Nishi A, Mukai H. Funayama M, et al. Among authors: mimura y. J Psychiatr Res. 2022 Jul;151:419-426. doi: 10.1016/j.jpsychires.2022.05.008. Epub 2022 May 13. J Psychiatr Res. 2022. PMID: 35597225
Impact of Amyloid and Tau PET on Changes in Diagnosis and Patient Management.
Shimohama S, Tezuka T, Takahata K, Bun S, Tabuchi H, Seki M, Momota Y, Suzuki N, Morimoto A, Iwabuchi Y, Kubota M, Yamamoto Y, Sano Y, Shikimoto R, Funaki K, Mimura Y, Nishimoto Y, Ueda R, Jinzaki M, Nakahara J, Mimura M, Ito D. Shimohama S, et al. Among authors: mimura y. Neurology. 2023 Jan 17;100(3):e264-e274. doi: 10.1212/WNL.0000000000201389. Epub 2022 Sep 29. Neurology. 2023. PMID: 36175151
Reduced signal propagation elicited by frontal transcranial magnetic stimulation is associated with oligodendrocyte abnormalities in treatment-resistant depression.
Wada M, Nakajima S, Honda S, Takano M, Taniguchi K, Tsugawa S, Mimura Y, Hattori N, Koike S, Zomorrodi R, Blumberger DM, Daskalakis ZJ, Mimura M, Noda Y. Wada M, et al. Among authors: mimura y. J Psychiatry Neurosci. 2022 Sep 14;47(5):E325-E335. doi: 10.1503/jpn.220102. Print 2022 Sep-Oct. J Psychiatry Neurosci. 2022. PMID: 36104082 Free PMC article.
39 results